Table 2.
Bioactive | Dose | Model | Health Effects of the Combination | Reference |
---|---|---|---|---|
Neurodegenerative Diseases | ||||
| ||||
EPA, Lyc-O-mato, carnosic acid, and lutein. | 0.125 µM EPA, 0.1 µM Lyc-O-mato, 0.2 µM carnosic acid and 0.2 µM lutein. | BV-2 immortalized murine microglial cell line. | Synergistic inhibition of the production of proinflammatory mediators: Inhibition redox-sensitive NF-κB activation; Inhibition of superoxide production; Upregulation COX-2 and iNOS; More release of PGE2 and NO; Attenuation IL-6 and CD40. |
[68] |
Polyphenols (resveratrol, quercetin, and apigenin), omega-3 and omega-9 fatty acids (α-ALA, EPA, DHA, and OA) and α-tocopherol. |
Polyphenols: 1.5 to 6.25 µM; Fatty acids: 6.25 to 50 µM. α-Tocopherol: 400 µM. |
N2a Neuronal cells. | Cytoprotective against 7-Ketocholesterol-induced neurotoxicity. | [69] |
| ||||
Resveratrol and DHA. | 50 mg/kg/day of each supplement (alone and combined); 6 weeks. |
Adult C57Bl/6 mice. | Modulation of steroid hormone biosynthesis, JAK-STAT signaling pathway, ribosome, graft-versus-host disease pathways in the hippocampus; Decreased IL-6 and Apolipoprotien E (ApoE) expression. |
[70] |
LMN diet rich in polyphenols and PUFAs. | LMN diet; 5 months. |
Tg2576 male and female mice as a model of AD. | Delays the Aβ plaque formation and decreases Aβ1–40 and Aβ1–42 plasma levels in adult mice. | [71] |
LMN diet rich in polyphenols and PUFAs. | LMN diet; 10, 20, 30, or 40 days. |
129S1/SvImJ adult male mice. | Enhancement of cholinergic and catecholaminergic transmissions; Nrf2 activation and increased protein levels of SOD-1 and GPx. |
[72] |
Resveratrol, prebiotic fiber, and DHA. | Resveratrol 50 mg/L drinking water; DHA and prebiotics in powdered food (100 g of prebiotic, 300 g of DHA, and 600 g of standard diet per 1 kg of food); Administration from post-natal day 21 to 43. |
Adolescent male and female Sprague–Dawley rats suffering from mild traumatic brain injury. | Modify premorbid characteristics Prevented injury-related deficits in longer-term behavior measures, medial prefrontal cortex spine density, and levels of Aqp4, Gfap, Igf1, Nfl, and Sirt1 expression in the prefrontal cortex. |
[73] |
Multivitamins, zinc, polyphenols, omega-3 fatty acids, and probiotics. | Bioactive mixture for 2 two weeks; 48 days. |
Crickets. | A combination of multivitamins, zinc, and omega-3 fatty acids was the most effective for improving memory and cognitive performance. | [74] |
| ||||
Smartfish® (omega-3 EPA and DHA, and resveratrol, vitamin D, and whey protein). | 200 mL/day Smartfish® drink containing 1000 mg DHA, 1000 mg EPA, pomegranate and chokeberry, 10 mg vitamin D3 and resveratrol, whey protein, fiber, and fruit juice; 4–17 months. |
Patients with minor cognitive impairment (MCI), with pre-MCI, or with Alzheimer disease (AD). | Increase amyloid-β phagocytosis and resolvin D1 in patients with MCI. | [75] |
Smartfish® (omega-3 EPA and DHA, and resveratrol, vitamin D, and whey protein). | 200 mL/day Smartfish® drink containing 1500 mg DHA and 1500 mg EPA, 10 μg vitamin D3, 150 mg resveratrol, and 8 g whey protein isolate; 6 months. |
Older adults (68–83 years) without any specific pathology. | Limited beneficial effects improving cognitive function. | [76] |
NEWSUP (high in plant polyphenols and omega-3 fatty acids, high fortification of micronutrients, and high protein content). | NEWSUP; 23 weeks. |
Children aged 15 months to 7 years; primary population: children younger than 4. | Increased working memory, hemoglobin concentration among children with anemia, decreased body mass index z score gainm, and increased lean tissue accretion with less fat; Increased index of cerebral blood flow (CBFi). |
[77] |
Cancer | ||||
| ||||
Curcumin and fish oil. | 1% (w/w) curcumin; 4% (w/w) menhaden fish oil; 3 weeks nutraceutical supplementation + genotoxic carcinogen injections + 17 weeks. |
Lgr5-EGFP-IREScreERT2 knock-in mice. | Only fish oils + curcumin reduced nuclear β-catenin in aberrant crypt foci and synergistically increased targeted apoptosis in DNA damaged Lgr5+ stem cells; Only fish oils + curcumin up-regulated p53 signaling in Lgr5+ stem cells from mice exposed to a carcinogen. |
[78] |
| ||||
PureVida™ (EPA/DHA/hydroxytyrosol/curcumin). |
3 capsules of PureVida™/day; Each capsule: 460 mg of fish oil (EPA and DHA), 125 mg of Hytolive® powder (12.5 mg of natural hydroxytyrosol), and 50 mg extract of curcumin (47.5 mg curcuminoids); 1 month. |
Post-menopausal breast cancer patients. | Decrease in CRP; Reduction of pain from aromatase inhibitors of hormonal therapies. |
[79] |
Mediterranean diet. | Mediterranean-type dietary pattern; Population-based case–control study; January 2015 to December 2016; Catania, Italy. |
Prostate cancer (PCa) cases and controls. | High adherence to diet inversely associated with the likelihood of prostate cancer: PCa cases consume a lower amount of vegetables, legumes, and fish. |
[80] |
Exercise and physical activity | ||||
| ||||
Fish oil and curcumin. | 5% fish oil (EPA: 13.2%; DHA: 8.6%; DPA: 4.9%), 1% curcumin in diet; 10 days supplement + 7 day hindlimb unloading. |
C57BI/6 mice. | Decreased loss of muscle cross-sectional area; An enhanced abundance of HSP70 and anabolic signaling (Akt phosphorylation, p70S6K phosphorylation) while reducing Nox2. |
[81] |
| ||||
Beverages based on almonds and olive oil and enriched with α-tocopherol and DHA. | 1 L daily supplementation of almond and olive oil and α-tocopherol based beverage enriched with a DHA functional beverage five days a week; 5 weeks. |
Young/senior male athletes. | Increased PUFAs and reduced SFAs in plasma; Increased DHA in erythrocyte; Increased blood cell polyphenol concentration in senior athletes; Protects against oxidative damage but enhances nitrative damage in young athletes; Gene expression of antioxidant enzymes in peripheral blood mononuclear cells after exercise in young athletes (GPx, CAT, and Cu–Zn SOD). |
[82] |
Beverages based on almonds and olive oil and enriched with α-tocopherol and DHA. | 1 L daily supplementation of almond and olive oil and α-tocopherol based beverage enriched with a DHA functional beverage five days a week; 5 weeks. |
Young/senior male athletes. | Increased TNFα levels depending on age and exercise;Attenuated the increase in plasma NEFAs, sICAM3 and sL-Selectin induced by exercise; Exercise increased PGE2 plasma levels in supplemented young athletes; Exercise increased NFkβ-activated levels in PBMCs mainly in supplemented young athletes. |
[83] |
Antioxidant/anti-inflammatory cocktail (polyphenols, vitamin E, selenium, and omega-3). | Daily antioxidant/anti-inflammatory cocktail (741 mg of polyphenols, 138 mg of vitamin E, 80 μg of selenium, and 2.1 g of omega-3); 60 days of hypoactivity. |
Healthy, active male subjects. | Ineffectiveness regarding oxidative muscle damage, mitochondrial content, and protein balance and a disturbance of essential signaling pathways (protein balance and mitochondriogenesis) during the remobilization period. | [84] |
Age-related eye disease | ||||
| ||||
Resvega (30 mg of trans resveratrol and 665 mg of omega-3 EPA and DHA, among other nutrients). | 288 ng of Resvega (30 mg of trans resveratrol and 665 mg of omega-3, among other nutrients); 48 h. |
ARPE-19 cells. | Induced autophagy by increased autolysosome formation and autophagy flux; Change p62 and LC3 protein levels; Cytoprotection under proteasome inhibition |
[85] |
| ||||
Resvega (30 mg of trans resveratrol and 665 mg of omega-3, among other nutrients). | 100 µL of Resvega once a day; 38 days. |
C57BL6/J mice. | Less vascular endothelial growth factor (VEGF) protein expression levels and less MMP-9 activity; Mitigate choroidal neovascularization and retinal disease. |
[86] |
Others | ||||
Dermatologic food (EPA + DHA + polyphenols). |
Dermatologic food; 8 weeks. |
Adult atopic dog. | Reductions in clinical scores of atopic dermatitis. | [87] |
Olive oil polyphenols and fish oil. | Prospective birth cohort Assessment of Lifestyle and Allergic Disease During INfancy (ALADDIN) Families recruited: September 2004–November 2007; Stockholm area, Sweden. |
Placentas. | Altered histone acetylation in placentas. | [88] |
Omega-3 fatty acids, and polyphenols, fiber. | Mother–neonate pairs from the prospective and observational MAMI birth cohort. Recruited: 2015–2017 Spanish–Mediterranean area; 18 months. |
Gut microbiota from mother–neonate pairs. | Higher abundance of the Ruminococcus species in maternal gut microbiota; Higher relative abundance of Faecalibacterium prausnitzii considered as a biomarker of colonic health, associated with anti-inflammatory properties; Modulation of neonatal microbiota. |
[89] |